|
|
 |
|
With bioadhesion, Gynazole·1 holds fast for
one-dose convenience |
|
Bioadhesion is a technology that enables compounds to adhere to wet living
tissue for a targeted, continuous release of medication. Gynazole·1 is the
only yeast infection treatment that employs the Site Release®
bioadhesion mechanism. That’s why Gynazole·1 cream can cling to the walls of the vagina
for one-dose, anytime administration.
|
 |
|
Exclusive bioadhesion technology keeps
Gynazole·1 at the site of the infection |
|
• Gynazole·1 stays at the site of the infection for a median
of 4.2 days, resulting in minimal leakage (5) |
|
• Extended release allows for effective single-dose treatment,
without doubling or tripling of drug concentration |
|
• Prefilled disposable applicator for easy dosing, less mess,
and less hassle |
|
One anytime dose and less mess for increased
compliance (3,4) |
|
• The only single-dose cream that can be administered any time
of the day or night (2,5) |
|
• Anytime dosing can be followed immediately by normal
activity |
|
|
| Important Gynazole•1 Information |
|
|
|
|
|
|
|
 |
| Fast Relief |
| FOR LESS |
Give your patients
$15 off their next prescription of
Gynazole•1 |
|
|
|
|
|
|
|
|
|
|
